190 related articles for article (PubMed ID: 26409700)
1. Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
Sandroff BM; Pilutti LA; Motl RW
NeuroRehabilitation; 2015; 37(1):149-55. PubMed ID: 26409700
[TBL] [Abstract][Full Text] [Related]
2. Physical fitness, walking performance, and gait in multiple sclerosis.
Sandroff BM; Sosnoff JJ; Motl RW
J Neurol Sci; 2013 May; 328(1-2):70-6. PubMed ID: 23522499
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Motl RW; Balantrapu S; Pilutti L; Dlugonski D; Suh Y; Sandroff BM; Lane A; Fernhall B
Eur J Phys Rehabil Med; 2013 Feb; 49(1):59-66. PubMed ID: 22820825
[TBL] [Abstract][Full Text] [Related]
4. Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance.
Cederberg KLJ; Sikes EM; Bartolucci AA; Motl RW
Gait Posture; 2019 Sep; 73():147-153. PubMed ID: 31326830
[TBL] [Abstract][Full Text] [Related]
5. Quantifying six-minute walk induced gait deterioration with inertial sensors in multiple sclerosis subjects.
Engelhard MM; Dandu SR; Patek SD; Lach JC; Goldman MD
Gait Posture; 2016 Sep; 49():340-345. PubMed ID: 27479220
[TBL] [Abstract][Full Text] [Related]
6. Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.
Sandroff BM; Klaren RE; Motl RW
J Neurol Phys Ther; 2015 Apr; 39(2):103-10. PubMed ID: 25742375
[TBL] [Abstract][Full Text] [Related]
7. Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.
Applebee A; Goodman AD; Mayadev AS; Bethoux F; Goldman MD; Klingler M; Blight AR; Carrazana EJ
Clin Ther; 2015 Dec; 37(12):2780-7. PubMed ID: 26565077
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
Goldman MD; Marrie RA; Cohen JA
Mult Scler; 2008 Apr; 14(3):383-90. PubMed ID: 17942508
[TBL] [Abstract][Full Text] [Related]
9. Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis.
Sandroff BM; Motl RW; Román CAF; Wylie GR; DeLuca J; Cutter GR; Benedict RHB; Dwyer MG; Zivadinov R
J Neurol; 2022 Oct; 269(10):5531-5540. PubMed ID: 35718819
[TBL] [Abstract][Full Text] [Related]
10. Six-Minute Walk as a Measure of Walking Capacity and Endurance in Patients With Pediatric-Onset Multiple Sclerosis.
Brenton JN; Florenzo B; Koshiya H; Min S; Woolbright E; Coleman R; Chen S; Goldman M
Neurology; 2022 Nov; 99(19):e2161-e2170. PubMed ID: 35985830
[TBL] [Abstract][Full Text] [Related]
11. Self-efficacy and Walking Performance in Persons With Multiple Sclerosis.
Motl RW; Balto JM; Ensari I; Hubbard EA
J Neurol Phys Ther; 2017 Apr; 41(2):114-118. PubMed ID: 28263255
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the different physiological significance of the 6- and 2-minute walk tests in multiple sclerosis.
Motl RW; Suh Y; Balantrapu S; Sandroff BM; Sosnoff JJ; Pula J; Goldman MD; Fernhall B
BMC Neurol; 2012 Mar; 12():6. PubMed ID: 22380843
[TBL] [Abstract][Full Text] [Related]
13. Physical activity and peak oxygen consumption are associated with walking in multiple sclerosis.
Hibner BA; Hilgenkamp TIM; Schroeder EC; Motl RW; Bollaert RE; Griffith G; Grigoriadis G; Baynard T; Fernhall B
Mult Scler Relat Disord; 2020 May; 40():101941. PubMed ID: 31954226
[TBL] [Abstract][Full Text] [Related]
14. Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test.
Adonis A; Taylor GP
PLoS One; 2016; 11(6):e0157132. PubMed ID: 27336911
[TBL] [Abstract][Full Text] [Related]
15. Accuracy of StepWatch™ and ActiGraph accelerometers for measuring steps taken among persons with multiple sclerosis.
Sandroff BM; Motl RW; Pilutti LA; Learmonth YC; Ensari I; Dlugonski D; Klaren RE; Balantrapu S; Riskin BJ
PLoS One; 2014; 9(4):e93511. PubMed ID: 24714028
[TBL] [Abstract][Full Text] [Related]
16. Accelerometry is associated with walking mobility, not physical activity, in persons with multiple sclerosis.
Weikert M; Suh Y; Lane A; Sandroff B; Dlugonski D; Fernhall B; Motl RW
Med Eng Phys; 2012 Jun; 34(5):590-7. PubMed ID: 21968005
[TBL] [Abstract][Full Text] [Related]
17. Physical Fitness Assessment Across the Disability Spectrum in Persons With Multiple Sclerosis: A Comparison of Testing Modalities.
Pilutti LA; Sandroff BM; Klaren RE; Learmonth YC; Platta ME; Hubbard EA; Stratton M; Motl RW
J Neurol Phys Ther; 2015 Oct; 39(4):241-9. PubMed ID: 26247510
[TBL] [Abstract][Full Text] [Related]
18. Accelerometry as a measure of walking behavior in multiple sclerosis.
Motl RW; Pilutti L; Sandroff BM; Dlugonski D; Sosnoff JJ; Pula JH
Acta Neurol Scand; 2013 Jun; 127(6):384-90. PubMed ID: 23240822
[TBL] [Abstract][Full Text] [Related]
19. Real-world walking in multiple sclerosis: Separating capacity from behavior.
Engelhard MM; Patek SD; Lach JC; Goldman MD
Gait Posture; 2018 Jan; 59():211-216. PubMed ID: 29078135
[TBL] [Abstract][Full Text] [Related]
20. Physical activity and walking performance across the lifespan among adults with multiple sclerosis.
Baird JF; Cederberg KLJ; Sikes EM; Silveira SL; Jeng B; Sasaki JE; Sandroff BM; Motl RW
Mult Scler Relat Disord; 2019 Oct; 35():36-41. PubMed ID: 31302502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
